Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long‐term application in patients with predominantly moderate acne with or without concomitant medication – additional results from the non‐interventional cohort study ELANG

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. S4, 2015-06 ,pp. : 23-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of adapalene/benzoyl peroxide combination in moderate inflammatory acne and its impact on patient adherence

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 6, 2015-06 ,pp. : 557-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1371-1383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland

By Przeklasa-Muszynska Anna   Dobrogowski Jan  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1109-1117

Informa Healthcare

Access to resources Recommend Favorite

A randomized investigator‐blind parallel‐group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 4, 2015-04 ,pp. : 789-796

John Wiley & Sons Inc

Access to resources Recommend Favorite